 |
폐암진료지침 3판
|
|
2023.12.06 |
6,589 |
 |
국가폐암검진 결과상담 전문인력 하이브리드 워크샵 다시보기
|
|
2023.10.11 |
1,158 |
 |
NCCN 가이드라인
|
|
2023.08.09 |
4,275 |
 |
국가폐암검진 질지침, 포켓북 안내
|
|
2023.08.08 |
1,383 |
8 |
NSCLC NCCN Guideline V.2.2009
|
|
2009.03.15 |
639 |
7 |
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 2009;45(2):228-247.
|
|
2009.03.15 |
784 |
6 |
Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline, Journal of Clinical Oncology, 2007;25(34):5506-5518
|
|
2008.01.03 |
316 |
5 |
Cancer Care Ontario and ASCO adjuvant chemotherapy and adjuvant RT for stage I-IIIA resectable NSCLC guideline
|
|
2007.11.07 |
294 |
4 |
Diagnosis and management of lung cancer: ACCP guidelines (2nd edition) Chest, Volume 132/Number 3 Supplement/September, 2007
|
|
2007.11.06 |
440 |
3 |
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline. Journal of Clinical Oncology 2004;22:330-353.
|
|
2007.11.06 |
291 |
2 |
SCLC, NCCN guideline v.1.2008
|
|
2007.11.06 |
332 |
1 |
NSCLC, NCCN guideline v.2.2008
|
|
2007.11.06 |
376 |